
Faboscot 80mg Tablet
Marketer
Adenscot Healthcare
Salt Composition
Febuxostat (80mg)
Overview Faboscot 80mg Tablet
Goutrex 80mg tablets effectively manage and prevent gout attacks. Gout arises from elevated uric acid levels, forming crystals that deposit in joints, causing inflammation and pain. This medication lowers uric acid, thereby reducing gout symptoms. Goutrex 80mg can be ingested with or without food. Continuous use, as prescribed, is crucial; cessation may exacerbate symptoms due to further crystal formation. Dietary adjustments (e.g., limiting alcohol and red meat) and increased fluid intake are beneficial. Potential side effects include liver enzyme abnormalities, nausea, arthralgia, and skin rashes. A temporary flare-up (intense joint pain, warmth, and erythema) may occur initially; however, discontinue only under medical guidance. Analgesics or other medications might alleviate this. Report any signs of liver dysfunction, such as persistent nausea, dark urine, or jaundice, immediately. Prior to commencing treatment, disclose any existing cardiovascular disease, stroke history, thyroid disorders, or hepatic or renal impairment. Avoid use during pregnancy or breastfeeding; consult your physician for advice. Regular blood tests are necessary to monitor liver function.
Primary Ingredients of Faboscot 80mg Tablet
The provided text is "undefined," which lacks meaning and cannot be rephrased. There is no text to rewrite.
Uses of Faboscot 80mg Tablet
Managing Gout
Major Benefits of Faboscot 80mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 80mg Faboscot tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent timing is recommended.
Common Side effects of Faboscot 80mg Tablet:
- Nausea
- Skin rash
- Abnormal liver function
- Joint pain
- Rash
How to use Faboscot 80mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 80mg Faboscot tablet whole; do not alter its form. While it can be taken with or without food, consistent timing is recommended for optimal results.
How Faboscot 80mg Tablet works:
Uricase inhibition is achieved by the xanthine oxidase inhibitor Faboscot 80mg Tablet, thus lowering the blood uric acid levels responsible for gout.
SAFETY ADVICE
AlcoholCAUTION
It's recommended to avoid alcohol while taking Faboscot 80mg tablets. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Faboscot 80mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Faboscot 80mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Faboscot 80mg Tablets, which can induce side effects such as dizziness, drowsiness, blurred vision, and numbness or tingling.
KidneyCAUTION
Caution is advised when prescribing Faboscot 80mg tablets to individuals with advanced renal impairment. Dosage modification for Faboscot 80mg tablets might be necessary. Physician consultation is recommended. Data on Faboscot 80mg tablet use in such patients is currently limited.
LiverCAUTION
Patients with severe hepatic impairment should use Faboscot 80mg tablets cautiously, potentially requiring dose modification. Physician consultation is advised, as data on Faboscot 80mg tablet use in such patients is limited.
What if you forget to take Faboscot 80mg Tablet :
Should you forget a dose of Faboscot 80mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Faboscot 80mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Thiazole-based compound |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
